Our Laboratory stood out in the Eikon 2023 Awards for excellence in Institutional Communication, winning two statuettes for the short film Luarprofeno: la otra respiración: – Gold Eikon in the category Brand Film Publications – Eikon Award for Innovation in Institutional Communication Campaigns During the COVID-19 pandemic, in conjunction with the Ministry of Health and…
The investigator in charge of the trial with nebulizable ibuprofen assures that there are controls and it complies with regulations. The Cordoba Medical Council criticized the haste in releasing the study. Last week, the first results of a treatment developed in Córdoba to treat patients with Covid-19 were released. It is a nebulizable ibuprofen formulation…
In 2014, a group of researchers from Ceprocoras part of the joint work carried out with our Laboratory, began research for the development of an innovative application aimed at treating severe pulmonary conditions, such as cystic pulmonary fibrosis, pneumonia and bronchiectasis. Today this product, still under development, presents a possibility in the face of the…